5 Key Takeaways

• 1

  Essilor’s Stellest® lenses were named one of TIME’s Best Inventions of 2026 in the Health & Wellness category.

• 2

  The FDA granted Stellest® lenses De Novo market authorization in September 2025.

• 3

  Stellest® lenses are the first and only FDA market-authorized spectacle lenses in the United States to slow myopia progression in children.

• 4

  The lenses received FDA Breakthrough Device designation in 2021.

• 5

  The article describes myopia as a rapidly growing vision challenge among children and notes that progressive myopia can affect long-term eye health.